XML 20 R9.htm IDEA: XBRL DOCUMENT v3.4.0.3
COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS
9 Months Ended
Mar. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS

NOTE 4. COMPOSITION OF CERTAIN FINANCIAL STATEMENT ITEMS

 

Inventory

 

Inventory is stated at the lower of cost (first-in, first-out) or market and consists of the following (in thousands):

 

    March 31,
2016
    June 30,
2015
 
Raw materials /purchased components   $ 2,031     $ 2,025  
Work in process     949       1,030  
Sub-assemblies /finished components     993       1,095  
Finished goods     145       160  
Total inventory   $ 4,118     $ 4,310  

 

Intangibles

 

Intangibles consist of the following (in thousands):

 

    March 31,
2016
    June 30,
2015
 
Capitalized software development costs   $ 73     $ 73  
Covenant not to compete     52       52  
Trade name     50       54  
Customer list and backlog     316       316  
Patent-related costs     96       96  
Total intangibles   $ 587     $ 591  
Less accumulated amortization     (145 )     (44 )
      442       547  

 

Capitalized software development costs relate to internally developed software, which are being amortized over the estimated minimum unit sales of the underlying product which was released during the fourth quarter of fiscal 2015. Both the covenant not to compete and the customer list and backlog relate to assets acquired in conjunction with the business acquisitions more fully described in Note 2 and are being amortized over various periods not to exceed ten years. The trade name relates exclusively to Fineline Molds and has an indefinite life, subject to impairment loss consideration annually, and more frequently if certain conditions exist (see Note 3). Patent-related costs consist of legal fees incurred in connection with patent applications, which we began amortizing in the third quarter of fiscal 2016 upon the related patent issuance, over a period of seven years, the estimated life of the product that is currently utilizing the patented technology.